NCT07537556

Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis

Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis.

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal is to compare clinical outcomes, hospital costs, and cost-utility in patients undergoing anatomical lung resections with DaVinci Xi vs Versius platforms The main questions it aims to answer are: * Do patients that undergo an anatomical lung resection with DaVinci Xi have the same clinical outcomes (complications, stay...) than those who were operated with Versius? * Are anatomical lung resections performed with DaVinci Xi more expensive than those performed with Versius? * Are anatomical lung resection performed with DaVinci Xi more cost-effective than those performed with Versius? Participants already undergoing robotic anatomical lung resection as part of their regular medical care will answer quality of life questionnaires preoperatively, at 1, 3, 6, and 12 months after surgery.

Conditions

• Pulmonary Nodule, Solitary
• Lung Cancer (NSCLC)
• Pulmonary Metastases

Interventions

Type	Name	Description
DEVICE	da Vinci Xi Surgical System	Robotic platform used to perform anatomical lung resection (lobectomy or segmentectomy)
DEVICE	Versius Surgical System	Robotic platform used to perform anatomical lung resection (lobectomy or segmentectomy)

Timeline

• Start date: 2023-04-01
• Primary completion: 2026-07-31
• Completion: 2026-07-31
• First posted: 2026-04-17
• Last updated: 2026-04-17

Locations

1 site across 1 country: Spain

Regulatory

• FDA-regulated device study